Response Genetics, Inc (RGDXQ)
Tests cancer tumors to predict which treatments will work best for patients.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
RGDXQ is trading at its 52-week high with price above both its 50- and 200-day moving averages, showing upward momentum in its trend. Analyst coverage appears thin for this micro-cap stock. The data reflects current positioning near recent peaks, though at this price level typical valuation metrics may be limited.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$1,365
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—